iBio, Inc. Files 424B3 Prospectus
Ticker: IBIO · Form: 424B3 · Filed: Apr 29, 2026 · CIK: 0001420720
| Field | Detail |
|---|---|
| Company | Ibio, Inc. (IBIO) |
| Form Type | 424B3 |
| Filed Date | Apr 29, 2026 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: prospectus, securities, filing
TL;DR
iBio filed a prospectus (424B3) on 4/29/26. Check it for investment details.
AI Summary
iBio, Inc. filed a 424B3 prospectus on April 29, 2026, related to its securities. The filing details information about the company's offerings and financial structure, with its principal executive offices located at 600 Madison Avenue, Suite 1601, New York, NY 10022-1737.
Why It Matters
This filing provides updated information to investors regarding iBio, Inc.'s securities, which is crucial for understanding potential investments and the company's financial standing.
Risk Assessment
Risk Level: medium — Prospectus filings (424B3) often relate to the issuance or sale of securities, which can carry inherent investment risks.
Key Numbers
- 424B3 — Form Type (Indicates a prospectus filing)
- 0001104659-26-050991 — SEC Accession Number (Unique identifier for the filing)
Key Players & Entities
- iBio, Inc. (company) — Filer of the prospectus
- 0001420720 (company) — CIK number for iBio, Inc.
- 2026-04-29 (date) — Filing date of the 424B3 prospectus
- 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737 (address) — Mailing and Business Address for iBio, Inc.
FAQ
What is the purpose of a 424B3 filing?
A 424B3 filing is a prospectus supplement used to provide additional information or updates to a previously filed registration statement, often related to the sale of securities.
When was this specific 424B3 filing by iBio, Inc. accepted by the SEC?
This filing was accepted by the SEC on April 29, 2026.
What is iBio, Inc.'s CIK number?
iBio, Inc.'s CIK number is 0001420720.
Where are iBio, Inc.'s principal executive offices located?
iBio, Inc.'s principal executive offices are located at 600 Madison Avenue, Suite 1601, New York, NY 10022-1737.
What is the SIC code for iBio, Inc. and what industry does it represent?
The SIC code for iBio, Inc. is 2834, which represents Pharmaceutical Preparations.
Filing Details
This Form 424B3 (Form 424B3) was filed with the SEC on April 29, 2026 regarding iBio, Inc. (IBIO).